Inventor
BUNKER KEVIN DUANE
US43 patents
⚠️ This page may combine multiple inventors who share the name “BUNKER KEVIN DUANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RECURIUM IP HOLDINGS LLC
25 patentsUS11339162B1May 24, 2022
Estrogen receptor modulators
RECURIUM IP HOLDINGS LLC3 citations72
US11813260B1Nov 14, 2023
Benzamide compounds
RECURIUM IP HOLDINGS LLC1 citations71
US11813259B2Nov 14, 2023
Benzamide compounds
RECURIUM IP HOLDINGS LLC1 citations71
US11590126B2Feb 28, 2023
Benzamide compounds
RECURIUM IP HOLDINGS LLC1 citations71
US11344546B2May 31, 2022
Benzamide compounds
RECURIUM IP HOLDINGS LLC1 citations71
US11261192B2Mar 1, 2022
Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones
RECURIUM IP HOLDINGS LLC5 citations71
US11098030B2Aug 24, 2021
EGFR inhibitor compounds
RECURIUM IP HOLDINGS LLC1 citations71
US10525036B2Jan 7, 2020
Spirocyclic compounds
RECURIUM IP HOLDINGS LLC2 citations71
US11999728B2Jun 4, 2024
Estrogen receptor modulators
RECURIUM IP HOLDINGS LLC0 citations62
US11124518B2Sep 21, 2021
L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogs
RECURIUM IP HOLDINGS LLC2 citations62
US10934304B2Mar 2, 2021
Spirocyclic compounds
RECURIUM IP HOLDINGS LLC0 citations62
US10793504B2Oct 6, 2020
Methods for cross coupling
RECURIUM IP HOLDINGS LLC1 citations62
USRE50643EOct 21, 2025
Benzamide compounds
RECURIUM IP HOLDINGS LLC0 citations61
US12049460B2Jul 30, 2024
EGFR inhibitor compounds
RECURIUM IP HOLDINGS LLC0 citations61
US11318134B2May 3, 2022
Benzamide compounds
RECURIUM IP HOLDINGS LLC0 citations61
US11065234B2Jul 20, 2021
Estrogen receptor modulators
RECURIUM IP HOLDINGS LLC1 citations61
US11065233B2Jul 20, 2021
Estrogen receptor modulators
RECURIUM IP HOLDINGS LLC0 citations61
US10959989B2Mar 30, 2021
Estrogen receptor modulators
RECURIUM IP HOLDINGS LLC0 citations61
US11724971B2Aug 15, 2023
Process for making [1.1.1]propellane
RECURIUM IP HOLDINGS LLC0 citations59
US11278532B2Mar 22, 2022
Estrogen receptor modulators for treating mutants
RECURIUM IP HOLDINGS LLC1 citations59
US10975035B2Apr 13, 2021
Bicyclic compounds
RECURIUM IP HOLDINGS LLC0 citations59
US11339103B2May 24, 2022
Continuous flow processes for making bicyclic compounds
RECURIUM IP HOLDINGS LLC0 citations56
US10653681B2May 19, 2020
Analgesic compounds
RECURIUM IP HOLDINGS LLC0 citations51
US11242327B2Feb 8, 2022
Analgesic compounds
RECURIUM IP HOLDINGS LLC0 citations50
US12410204B2Sep 9, 2025
Chiral synthesis of a tertiary alcohol
RECURIUM IP HOLDINGS LLC0 citations49
KALYRA PHARMACEUTICALS INC
9 patentsUS9693975B2Jul 4, 2017
Bicyclic analgesic compounds
KALYRA PHARMACEUTICALS INC12 citations92
US9447025B2Sep 20, 2016
Bicyclic analgesic compounds
KALYRA PHARMACEUTICALS INC15 citations92
US9724316B2Aug 8, 2017
Bicyclic analgesic compounds
KALYRA PHARMACEUTICALS INC6 citations83
US9447026B2Sep 20, 2016
Bicyclic analgesic compounds
KALYRA PHARMACEUTICALS INC9 citations83
US10251851B2Apr 9, 2019
Bicyclic analgesic compounds
KALYRA PHARMACEUTICALS INC2 citations72
US10189780B2Jan 29, 2019
Bicyclic alkyl compounds and synthesis
KALYRA PHARMACEUTICALS INC2 citations72
US10308609B2Jun 4, 2019
Bicyclic compounds
KALYRA PHARMACEUTICALS INC2 citations69
US10513509B2Dec 24, 2019
EGFR inhibitor compounds
KALYRA PHARMACEUTICALS INC1 citations61
US10654812B2May 19, 2020
Propellane derivates and synthesis
KALYRA PHARMACEUTICALS INC0 citations41
IMMUNOME INC
6 patentsUS12186403B2Jan 7, 2025
Immunoconjugates and methods
IMMUNOME INC1 citations72
US12285492B2Apr 29, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12280121B2Apr 22, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12274754B2Apr 15, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12268750B2Apr 8, 2025
Immunoconjugates and methods
IMMUNOME INC0 citations60
US12545716B2Feb 10, 2026
Immunoconjugates and methods
IMMUNOME INC0 citations50